Investigational gefurulimab met its primary efficacy endpoint in adults with anti-acetylcholine receptor (AChR) ...

Three popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type 2 ...

The Centers for Medicare & Medicaid Services (CMS) on Friday finalized its annual physician fee schedule for 2026, giving ...

Physical activity has been identified as a modifiable risk factor for dementia, but its relationship with Alzheimer's ...

Bank A was the largest, with 2,554 encounters (average 30.1 eggs retrieved), followed by Bank B with 2,269 (average 28.0 eggs ...

Involuntary movements caused by tardive dyskinesia (TD), a movement disorder induced by dopamine-receptor antagonists like ...

SAN FRANCISCO -- Two studies demonstrated the benefits of treating juvenile myasthenia gravis (MG) with newer drugs.

The FDA released a new scientific analysis Friday, concluding that fluoride supplements have limited benefits for children's ...